Formulation and Evaluation of Finasteride Sustained-Release Matrix Tablets Using Different Rate Controlling Polymers

    December 2016 in “ Universal journal of pharmaceutical research ”
    Igwe J. Chibueze, Emenike, Oduola A R
    Image of study
    TLDR Finasteride, a drug used for anti-hyperplasia, can be effectively delivered in the form of matrix tablets.
    The study from 6 years ago aimed to develop oral controlled release matrix tablet formulations of Finasteride, a synthetic 4-azasteroid drug used in the treatment of anti-hyperplasia, with different polymer ratios. Five varieties of tablets were compressed using polymers (HPMC, EC, Eudragit RS100) in different ratios and evaluated for various physical characteristics and in vitro release studies. The formulation MT5 showed a high hardness value of 4.8±0.22 kg/cm2, and matrix tablets of batch MT1 showed maximum release of 86.42% in 10 hours. The study concluded that all formulations complied with the specifications of official pharmacopoeias and/or standard references, and Finasteride can be effectively delivered in the form of matrix tablets.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Minoxidil Sulfate makes everyone a responder

      in Research/Science  255 upvotes 1 week ago
      Minoxidil sulfate is more effective than regular minoxidil, especially for those with low sulfotransferase levels or scalp sensitivity, but it is unstable unless delivered in a liposomal format. Combining minoxidil with tretinoin can enhance effectiveness, and stopping minoxidil use can lead to rapid hair loss.

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  44 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community Bile Acid-Mediated DHT Dysregulation Hypothesis

      in Research/Science  13 upvotes 2 weeks ago
      Elevated bile acids can inhibit the enzyme AKR1C2, leading to increased DHT levels, which may accelerate hair loss in those predisposed to androgenetic alopecia. Treatments mentioned include topical minoxidil and finasteride.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  136 upvotes 7 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

    Similar Research

    5 / 1000+ results